Skip Navigation LinksHome > May 2014 - Volume 20 - Issue 3 > Memantine in the Treatment and Prophylaxis of Bipolar II Dis...
Journal of Psychiatric Practice:
doi: 10.1097/01.pra.0000450324.44661.12
Clinical Case Discussions

Memantine in the Treatment and Prophylaxis of Bipolar II Disorder and Comorbid Fibromyalgia: A Case Report

SERRA, GIULIA MD; DE CHIARA, LAVINIA MD; KOUKOPOULOS, ALEXIA EMILIA MD; KOUKOPOULOS, ATHANASIOS MD; SERRA, GINO MD; KAHN, DAVID A. MD

Collapse Box

Abstract

We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy. We have also observed an acute antimanic and sustained mood-stabilizing effect in a small number of patients with bipolar I disorder who had had minimal previous pharmacotherapy. In this article, we report the case of a young woman suffering from bipolar II disorder with associated fibromyalgia, in whom memantine showed an acute antimanic and a long-term prophylactic effect on both bipolar disorder as well as the associated fibromyalgia syndrome. (Journal of Psychiatric Practice 2014;20:232–236)

Copyright © 2014 Lippincott Williams & Wilkins Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.